Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intensive Outpatient Treatment for Suicidal Veterans (CAMS)

This study has been completed.
Sponsor:
Collaborators:
The Catholic University of America
Information provided by:
VA Eastern Colorado Health Care System
ClinicalTrials.gov Identifier:
NCT01334372
First received: April 11, 2011
Last updated: April 12, 2011
Last verified: April 2011
  Purpose

This investigation is a feasibility study conducted in a VA outpatient treatment setting. The study is designed to test the feasibility of implementing a novel way of working with suicidal patients, the Collaborative Assessment and Management of Suicidality (CAMS). The primary purpose of the proposed project is to determine if it is possible to train clinicians working in the Mental Health Clinic at the Denver VA Medical Center (VAMC) to utilize this therapeutic framework. This project is extremely timely in relation to expectations of future increased clinical demands among potentially high-risk Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) veterans who may become suicidal in the years to come.


Condition Intervention
Suicidality
Behavioral: CAMS

Study Type: Interventional
Official Title: Intensive Outpatient Treatment for Suicidal Veterans: A Randomized Clinical Trial and Feasibility Investigation

Further study details as provided by VA Eastern Colorado Health Care System:

Enrollment: 48
Study Start Date: February 2007
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Treatment as Usual
Treatment as usual (TAU) outpatient care will consist of existing outpatient clinical practices utilized in the Mental Health Clinic.
Experimental: CAMS
First, as discussed above, suicidality is the focus of treatment rather than one of many symptoms being treated. Second is the emphasis on patient and therapist collaborating on treatment rather than the therapist dictating how therapy progresses. Beyond those two basic tenets, each therapist is free to utilize their current clinical skills to conduct psychotherapy.
Behavioral: CAMS
First, as discussed above, suicidality is the focus of treatment rather than one of many symptoms being treated. Second is the emphasis on patient and therapist collaborating on treatment rather than the therapist dictating how therapy progresses. Beyond those two basic tenets, each therapist is free to utilize their current clinical skills to conduct psychotherapy.

  Eligibility

Ages Eligible for Study:   18 Years to 89 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Suicidality endorsed during the regular Mental Health intake interview or at the time of admission.
  2. Over the age of 18 years.
  3. New or returning patients to the VA MHC.
  4. Living within the larger Denver metropolitan region during the duration of the treatment.
  5. Willing to travel to the ECHCS Denver VAMC at times other than scheduled therapy appointments to complete follow-up assessment measures.

Exclusion Criteria:

  1. Psychosis that would interfere with an individual's ability to provide informed consent.
  2. Imminent suicidality with the need for immediate psychiatric hospitalization, as defined above in the Background section, at the time of MH intake.
  3. Current involuntary status for psychiatric hospitalization.
  4. Inability to adequately respond to questions regarding the informed consent procedure. See Special Consent Issues section below.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01334372

Locations
United States, Colorado
Visn 19 Mirecc
Denver, Colorado, United States, 80220
Sponsors and Collaborators
VA Eastern Colorado Health Care System
The Catholic University of America
Investigators
Principal Investigator: Lisa A Brenner, PhD Department of Veterans Affairs
  More Information

No publications provided

Responsible Party: Lisa Brenner, VISN 19 Mental Illness Research, Education, and Clinical Center
ClinicalTrials.gov Identifier: NCT01334372     History of Changes
Other Study ID Numbers: 06-1058
Study First Received: April 11, 2011
Last Updated: April 12, 2011
Health Authority: United States: Federal Government

Keywords provided by VA Eastern Colorado Health Care System:
suicide
veterans
assessment
CAMS

ClinicalTrials.gov processed this record on November 25, 2014